Search for European Projects

Over 40 European Projects Found

Searched on 125080 European Projects

 FINISHED 

An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century (EU-ToxRisk)

Start date: Jan 1, 2016, End date: Dec 31, 2021,

The vision of EU-ToxRisk is to drive a paradigm shift in toxicology towards an animal-free, mechanism-based integrated approach to chemical safety assessment. The project will unite all relevant disciplines and stakeholders to establish: i) pragmatic, solid read-across procedures incorporating mechanistic and toxicokinetic knowledge; and ii) ab initio hazard and risk assessment strategies of chemi ...
Read Project

 43

 FINISHED 

Collective effects and optomechanics in ultra-cold matter (ColOpt)

Start date: Jan 1, 2017, End date: Dec 31, 2020,

The network “Collective effects and optomechanics in ultra-cold matter” (ColOpt) will train early-stage researchers (ESR) in fundamental science and applications in the areas of cold atom and quantum physics, optical technologies and complexity science to promote European competiveness in emergent quantum technologies. It consists of nine academic nodes and three companies from six European countr ...
Read Project

 13

 FINISHED 

An integrated interdisciplinary approach to animal-free chemical and nanomaterial safety assessment (in3)

Start date: Jan 1, 2017, End date: Dec 31, 2020,

All chemicals whether they are drugs, cosmetics, agrochemicals or others need to be tested for their safety to man and the environment. The use of whole animal studies for the prediction of adverse effects in man, is problematic due to species dependent effects, high costs and a large burden to animals in terms of numbers and suffering. While there have been major improvements in human in vitro a ...
Read Project

 14

 FINISHED 

Robots Understanding Their Actions by Imagining Their Effects (IMAGINE)

Start date: Jan 1, 2017, End date: Dec 31, 2020,

"Today's robots are good at executing programmed motions, but they do not understand their actions in the sense that they could automatically generalize them to novel situations or recover from failures. IMAGINE seeks to enable robots to understand the structure of their environment and how it is affected by its actions. "Understanding" here means the ability of the robot (a) to determine the ap ...
Read Project

 8

 FINISHED 

European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates (EHVA)

Start date: Jan 1, 2016, End date: Dec 31, 2020,

Many HIV vaccine concepts and several efficacy trials have been conducted in the prophylactic and therapeutic fields with limited success. There is an urgent need to develop better vaccines and tools predictive of immunogenicity and of correlates of protection at early stage of vaccine development to mitigate the risks of failure. To address these complex and challenging scientific issues, the Eur ...
Read Project

 43

 FINISHED 

The artificial pancreas in children aged 1 to 7 years with type 1 diabetes (KidsAP)

Start date: Jan 1, 2017, End date: Jun 30, 2020,

TYPE 1 DIABETES is one of the most COMMON CHRONIC diseases in children with a RAPID increase in number of cases particularly in young children. Type 1 diabetes is associated with LIFE-LONG dependency on insulin administration. POOR glucose control leads to diabetes COMPLICATIONS, e.g. eye, heart, kidney disease, including BRAIN changes in young children. Episodes of VERY LOW glucose levels may be ...
Read Project

 14

 FINISHED 

Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone (FAIR-PARK-II)

Start date: May 1, 2015, End date: Apr 30, 2020,

Parkinson’s disease (PD) is a major, chronic, non-communicable disease and the 2nd most frequent neurodegenerative disorder worldwide. Excess iron is primarily detected in the substantia nigra pars compacta, where dopaminergic neurons are exposed to high levels of oxidative stress produced by mitochondrial disorders and dopamine metabolism. Our previous preclinical, translational and pilot clinica ...
Read Project

 17

 FINISHED 

Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time (MDS-RIGHT)

Start date: May 1, 2015, End date: Apr 30, 2020,

Myelodysplastic syndromes (MDS) are chronic bone marrow malignancies of the elderly, complicated by severe anaemia. MDS significantly affects quality-adjusted survival and it imposes an increasing financial burden on patients and healthcare (HC) systems. The burden of disease is expected to worsen in the future, given the aging EU population and newly identified MDS cases among those diagnosed wit ...
Read Project

 16

 FINISHED 

Reason for Hope - Reintroduction of Northern Bald Ibis in Europe (LIFE Northern Bald Ibis)

Start date: Jan 1, 2014, End date: Dec 31, 2019,

Background The northern bald ibis is listed as ‘critically endangered’, with only one remaining colony in Morocco (consisting of around 200 adults) and a few individuals in the Middle East. A further colony with up to 100 individuals exists in Birecik, Turkey. Though these birds are a remnant of a former migratory colony that is now semi-captive, they ...
Read Project

 9

 FINISHED 

Development of Biomaterial-based Delivery Systems for Parkinson’s disease - an Integrated Pan-European Approach (BrainMatTrain)

Start date: Jan 1, 2016, End date: Dec 31, 2019,

BrainMatTrain focuses on a comprehensive understanding of Parkinson’s disease (PD), from basics to translation, fully supported by 8 full partners partner organisation (4 research institutions, 2 hospitals, 2 SMEs) and one partner organisation (SME specialist in device design). This ETN will educate and train 15 Earlty Stage Researchers (ESRs) in functioanlised biomaterials, materials science, fun ...
Read Project

 8

 FINISHED 

OpenRiskNet: Open e-Infrastructure to Support Data Sharing, Knowledge Integration and in silico Analysis and Modelling in Risk Assessment (OpenRiskNet)

Start date: Dec 1, 2016, End date: Nov 30, 2019,

Toxicology and risk assessment are undergoing a paradigm shift, from a phenomenological to a mechanistic discipline based on in vitro and in silico approaches that represent an important alternative to classical animal testing applied to the evaluation of chronic and systemic toxicity risks. Large databases and highly sophisticated methods, algorithms and tools are available for different tasks su ...
Read Project

 14

 FINISHED 

Training Network for the Immunotherapy of Cancer (IMMUTRAIN)

Start date: Dec 1, 2015, End date: Nov 30, 2019,

In the European Union, cancer is the leading cause of death and the overall cancer incidence is still increasing. As a result of expanding efforts to improve cancer outcome, a main paradigm change is occurring in cancer therapy towards individualized medicine. Antibody-based therapies form an integral and constantly growing part of this approach. Antibody-based therapies will strongly influence th ...
Read Project

 9

 FINISHED 

Astrophysics

Start date: Oct 1, 2015, End date: Sep 30, 2019,

Objective The main objectives of the Erasmus Mundus Joint Master Degree programme in Astronomy and Astrophysics are initiation in scientific research and applied training in Astronomy and Astrophysics.Course duration Two years (120 ECTS)Brief DescriptionThe various specialities of the partner institutions result in an increased offer of pathways for the students: Theoretical Astrophysics, Models, ...
Read Project

 5

 FINISHED 

From Omics to Patient: Improving Diagnostics of Pathogenic Yeasts (OPATHY)

Start date: Sep 1, 2015, End date: Aug 31, 2019,

OPATHY is an innovative translational research training network that will explore the potential of omics technologies, including genomics, transcriptomics and proteomics, to study the interactions of yeasts that cause disease to humans (e.g. Candida and Cryptococcus sp.) with their host, and to develop new diagnostic tools to monitor yeast infections in the clinic. Today, these infections are poor ...
Read Project

 10

 FINISHED 

Recognition and Enrichment of Archival Documents (READ)

Start date: Jan 1, 2016, End date: Jun 30, 2019,

"The overall objective of READ is to implement a Virtual Research Environment where archivists, humanities scholars, computer scientists and volunteers are collaborating with the ultimate goal of boosting research, innovation, development and usage of cutting edge technology for the automated recognition, transcription, indexing and enrichment of handwritten archival documents. This Virtual Resear ...
Read Project

 15

 FINISHED 

A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer (GANNET53)

Start date: Oct 1, 2013, End date: Mar 31, 2019,

"Epithelial ovarian cancer (EOC) is the most lethal gyncaecological malignancy causing 41900 deaths annually in Europe. The predominance of aggressive Type II tumours, which are characterised by a high frequency of p53 mutations, and primary or acquired resistance to platinum-based chemotherapy profoundly contribute to the high mortality rate. With current standard therapy the median overall survi ...
Read Project

 20

 FINISHED 

INADAR - Innovative and ecological approach for dam restoration (LIFE+ INADAR)

Start date: Aug 1, 2015, End date: Jan 31, 2019,

Background The banks of most water bodies containing dams today are covered with wave breakers made of concrete. They commonly don’t host ecologically rich habitats. According to the Water Framework Directive, these water bodies are considered to be “significantly modified water bodies". The water resides longer in them, leading to possible higher wat ...
Read Project

 3

 FINISHED 

Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease: Comparative Effectiveness Research of Existing Technologies (DISCHARGE)

Start date: Feb 1, 2014, End date: Jan 31, 2019,

Coronary artery disease (CAD) is the leading cause of death in high-income countries. Invasive coronary angiography (ICA) is the reference standard for the diagnosis of CAD and allows immediate therapy. However, only 40% of patients undergoing ICA actually have obstructive CAD and ICA has relatively rare but considerable risks. Coronary computed tomography (CT) is the most accurate diagnostic test ...
Read Project

 38

 FINISHED 

Multimodal Imaging of rare Synucleinopathies (MultISyn)

Start date: Oct 1, 2013, End date: Sep 30, 2018,

Despite remarkable progress in the understanding of the molecular pathogenesis of neurodegenerative diseases (NDD), no causative or disease-modifying treatment is currently available. Aggregation of misfolded proteins are thought to play a crucial role in the pathogenesis, but attempts to exploit this knowledge for novel treatments have not been successful. Also, pathogenetically relevant biomarke ...
Read Project

 9

 FINISHED 

Health Care Work Exchange 2016

Start date: Jun 1, 2016, End date: May 31, 2018,

...roughout Germany are actively involved in the project partner network “Health Care Work Exchange” administered by the EU Liaison Office (EU-Hochschulbüro Hannover/ Hildesheim) at the Leibniz Universität Hannover. Meanwhile more than a hundred partner organizations throughout Europe, such as university teaching hospitals, private medical practices, rehabilitation centers, public and private hospita ...
Read Project

 39

 FINISHED 

APERIM: Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy (APERIM)

Start date: May 1, 2015, End date: Apr 30, 2018,

Cancer treatment platforms that involve the use of the adaptive immune system have demonstrated profound tumour regressions including complete cure. Importantly, technological advances in next-generation sequencing (NGS) allow for the first time the development of personalised cancer immunotherapies that target patient specific mutations. However, clinical application is currently hampered by spec ...
Read Project

 11

 FINISHED 

Human Brain Project Specific Grant Agreement 1 (HBP SGA1)

Start date: Apr 1, 2016, End date: Mar 31, 2018,

Understanding the human brain is one of the greatest scientific challenges of our time. Such an understanding can provide profound insights into our humanity, leading to fundamentally new computing technologies, and transforming the diagnosis and treatment of brain disorders. Modern ICT brings this prospect within reach. The HBP Flagship Initiative (HBP) thus proposes a unique strategy that uses I ...
Read Project

 126

 FINISHED 

Rydberg Quantum Simulators (RYSQ)

Start date: Mar 1, 2015, End date: Feb 28, 2018,

Quantum Simulators provide new levels of understanding of equilibrium and out-of-equilibrium properties of many-body quantum systems, one of the most challenging problems in physics. The main objective of the RYSQ project is to use Rydberg atoms for quantum simulations, because their outstanding versatility will allow us to perform a great variety of useful quantum simulations, by exploiting diffe ...
Read Project

 16

 FINISHED 

Clearing Clutter Bit by Bit (SQUIRREL)

Start date: Feb 1, 2014, End date: Jan 31, 2018,

Clutter in an open world is a challenge for many aspects of robotic systems, especially for autonomous robots deployed in unstructured domestic settings, affecting navigation, manipulation, vision, human robot interaction and planning.SQUIRREL addresses these issues by actively controlling clutter and incrementally learning to extend the robot's capabilities while doing so. We term this the B3 (bi ...
Read Project

 10

 FINISHED 

Utility of omic-based biomarkers in characterizing older individuals at risk for frailty, its progression to disability and general consequences to health and well-being - The FRAILOMIC Initiative (FRAILOMIC)

Start date: Jan 1, 2013, End date: Dec 31, 2017,

The forecasted increase in the number of older people for this century will be accompanied by an increase of those with disabilities. Disability is usually preceded by a condition named frailty that encompasses changes associated with ageing, life styles and chronic diseases. To detect and intervene on it is of outstanding importance to prevent disability, as recovery from disability is unlikely. ...
Read Project

 29

 FINISHED 

European Clinical Research Infrastructures Network - Integrating Activity (ECRIN-IA)

Start date: Jan 1, 2012, End date: Dec 31, 2017,

ECRIN is a distributed ESFRI-roadmap pan-European infrastructure designed to support multinational clinical research, making Europe a single area for clinical studies, taking advantage of its population size to access patients. Servicing multinational trials started during its preparatory phase, and it now applies for an ERIC status by 2011. The ERIC budget will be restricted to core activities re ...
Read Project

 48

 FINISHED 

Cold Molecular Ions at the Quantum Limit (COMIQ)

Start date: Nov 1, 2013, End date: Oct 31, 2017,

"COMIQ (COld Molecular Ions at the Quantum limit)will investigate how cooling, trapping, and control techniques applied molecular ion can expand the realm of quantum technology, enhance precision meaurements on molecular systems and lead to chemistry at the ultracold quantum limit."
Read Project

 10

 FINISHED 

Higher education student and staff mobility project

Start date: Jun 1, 2016, End date: Sep 30, 2017,

This is a higher education student and staff mobility project, please consult the website of the organisation to obtain additional details.
Read Project

 1

 FINISHED 

Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC) (STEMBANCC)

Start date: Oct 1, 2012, End date: Sep 30, 2017,

StemBANCC, comprising internationally renowned investigators, is ideally positioned to deliver a unique European biorepository and drug discovery pipeline based upon human induced pluripotent stem cells (hiPSC). This unrivalled opportunity will address the pressing therapeutic need in neurodegeneration, neurodysfunction and diabetes. We have immediate access to richly phenotyped subjects with a we ...
Read Project

 38

 FINISHED 

Reach α-synuclein-dependent neurodegeneration: clinical development of therapeutic AFFITOPE vaccines for Parkinson’s disease and multisystem atrophy (SYMPATH)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

The goal of SYMPATH is to advance clinical development of therapeutic vaccines targeting α-synuclein (aSyn)-driven neurodegenerative diseases (ND). It addresses Parkinson’s disease (PD) and multiple system atrophy (MSA), two synucleopathies, for which no causal therapy exists. Ultimately, both lead to patient disability and death, which along with patient number (PD) and age of onset (MSA, PD) def ...
Read Project

 8

 FINISHED 

Non-coding RNAs in neurogenic and neuropathic pain mechanisms and their application for risk assessment, patient stratification and personalised pain medicine (NCRNAPAIN)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

Neuro-immune alterations in the peripheral and central nervous system play a role in the pathophysiology of chronic pain, and non-coding RNAs (ncRNAs) regulate both immune and neuronal processes. Therefore, ncRNAPain proposes that ncRNAs are critically important master switches for chronic pain.ncRNAPain represents a multidisciplinary consortium of clinical partners, molecular and systems-level n ...
Read Project

 12

 FINISHED 

Solar Heat Integration Network (SHINE)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

Large solar heating systems are decisive to cover a major part of European low temperature heat demand by solar energy and therewith to meet European policy aims. However, today only a negligible share of solar heating systems installed in Europe are large units due to manifold technical and socio-economic obstacles. The challenge of solar thermal technology and the overall objective of the propos ...
Read Project

 11

 FINISHED 

Semi-Autonomous 3rd Hand (3rd HAND)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

Robots have been essential for keeping industrial manufacturing in Europe. Most factories have large numbers of robots in a fixed setup and few programs that produce the exact same product hundreds of thousands times. The only common interaction between the robot and the human worker has become the so-called "emergency stop button". As a result, re-programming robots for new or personalized produc ...
Read Project

 4

 FINISHED 

Closed-loop Molecular Environment for Minimally Invasive Treatment of Patients with metastatic Gastrointestinal Stromal Tumours (MITIGATE)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

Gastrointestinal stromal tumours (GIST) are a rare disease that metastasises in up to 85% of patients with subsequent median progression-free survival (PFS) of only around 30 months. Tumours are characterised by activating mutations in the KIT or the PDGFRA gene and therefore treatment is mainly based on tyrosine kinase inhibitors designed to block these mutated receptors. However, drug resistance ...
Read Project

 10

 FINISHED 

International Learning Platform for Accountancy

Start date: Sep 1, 2014, End date: Aug 31, 2017,

The title of the project is “International Learning Platform for Accountancy (ILPA)”. Accountancy includes Financial Reporting, Auditing of Financial Statements, Financial Statement Analysis and Corporate Social Responsibility (CSR) Reporting. Graduates of a University or Business School with a specialisation in accountancy do need specific competence (knowledge, skills, values, ethics and attitud ...
Read Project

 10

 FINISHED 

DOKONARA

Start date: Sep 1, 2014, End date: Aug 31, 2017,

The aim of DOKONARA - doctoral colloquium in sustainable spatial planning - is to provide scientific debates and an interdisciplinary dialogue on ongoing dissertations, including their research questions, theoretical backgrounds and empirical designs. Submissions from PhD candidates working in sustainability dimensions of Regional Development and Planning, Urban Design, Architecture, Urban and Reg ...
Read Project

 4

 FINISHED 

VitaminD3-Omega3-Home Exercise- HeALTHy Ageing and Longevity Trial (DO-HEALTH)

Start date: Jan 1, 2012, End date: Jun 30, 2017,

As the European population is ageing rapidly, the growing number of seniors with age-related chronic diseases poses a challenge on European societies and health care systems. Therapeutic interventions that are effective, affordable and well-tolerated in the prevention of chronic disease are urgently needed and will have an outstanding impact on public health as a whole. Among the most promising in ...
Read Project

 25

 FINISHED 

Health Care Work Exchange 2015

Start date: Jun 1, 2015, End date: May 31, 2017,

...nd training abroad. Since 2007 over 30 vocational schools throughout Germany have joined a consortium administered by the EU Liaison Office (EU-Hochschulbüro Hannover/ Hildesheim) at the Leibniz Universität Hannover with the aim to design and implement a mobility project that meets students’ needs for high-quality and technically challenging internships abroad. In addition, more than 100 partner o ...
Read Project

 38

 FINISHED 

MOBILISING THE POTENTIAL OF ACTIVE AGEING IN EUROPE (MOPACT)

Start date: Mar 1, 2013, End date: Feb 28, 2017,

The starting point for MOPACT is the ambitious goals set by Horizon 2020 and the European Innovation Partnership Pilot Project on Active and Healthy Ageing (EIPAHA). Our response is ambitious too: we aim to provide the research and practical evidence upon which Europe can make longevity an asset for social and economic development. MOPACT will create a high quality, multi-disciplinary critical mas ...
Read Project

 32

 FINISHED 

Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk (ABIRISK)

Start date: Mar 1, 2012, End date: Feb 28, 2017,

The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia and multiple sclerosis, caring for ~30,000 patients treated with biopharmaceuticals, with ~10,000 additional patients recru ...
Read Project

 39